Emerging Biotech · Vaccines
The Post-COVID-19 State of Biomanufacturing News from the Biotech Start-up Symposium
During last month’s Biotech Start-up Symposium, attendees heard an all-star team of experts discuss the intricacies of raising…
Thomas C. Ransohoff, M.S is currently Technical Head, Biologicals Franchise at National Resilience, Inc. (“Resilience”) and has over 30 years of experience in the biopharmaceutical industry. Mr. Ransohoff’s areas of expertise include development and scale-up of biopharmaceutical processes; separations and purification technologies; cGMP manufacturing; and management of technology-based start-up ventures. Before joining Resilience, Mr. Ransohoff was a Managing Director at BDO and its precursor BPTC, a leading CMC consulting firm that he helped build over a 20 year period. Prior to that, he held senior level positions at TranXenoGen, Dyax, Repligen, and Xoma. He is also a co-founder of several successful start-ups, including 4th Dimension Bioprocess, Tarpon Biosystems and BioFlash Partners. He serves on a number of scientific and professional advisory boards and holds a Bachelor’s degree from MIT and a Master’s degree from the University of California, Berkeley, both in Chemical Engineering.
During last month’s Biotech Start-up Symposium, attendees heard an all-star team of experts discuss the intricacies of raising…